Zevra Therapeutics
Zevra Therapeutics is a development-stage biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. The company’s primary efforts include the development of safer, abuse-resistant opioid pain relievers. Its drug discovery and development platform is based on its proprietary Ligand Activated Therapy (LAT) approach. KemPharm uses its patent-applied technology to improve existing drugs and shorten the development timeline while still maintaining a strong intellectual property position within each therapeutic area.
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does Zevra Therapeutics use?+
Zevra Therapeutics uses 18 technologies including Bootstrap, WordPress, CookieYes.
What industry is Zevra Therapeutics in?+
Zevra Therapeutics operates in the Biotechnology industry.
Where is Zevra Therapeutics based?+
Zevra Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026